HopeStage
Back to all studies
CompletedNCT01691092

Brain Glutamate Imaging During Ketamine Research for Depression

About this titleRead the official source — NCT01691092
Medication studyAges 18–65United StatesPTSD
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

What did participation involve?

The study group receives ketamine as a study medication.

Listed locations
New Haven and 2 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 2012
Recruitment status
Completed
Enrollment listed in the registry
79
Sponsor
Yale University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT01691092
Official title
Show the full official title

PET Imaging of mGluR5 With Drug Challenge

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Did this study involve medication?

Yes. The study involved medication, including ketamine.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies